Financials KMS Medisurgi Limited
Equities
KMSMEDI6
INE870V01014
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125 INR | +2.53% | -.--% | +2.53% |
Valuation
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 99.5 | 99.66 | 108.9 | 112.5 | 113.7 | 229.8 |
Enterprise Value (EV) 1 | 103.1 | 99.18 | 117 | 116.7 | 119.5 | 237.8 |
P/E ratio | 104 x | 80.9 x | 96.9 x | 91.6 x | 52.8 x | 40.1 x |
Yield | 0.17% | 0.17% | 0.15% | 0.15% | 0.15% | 0.07% |
Capitalization / Revenue | 1.36 x | 1.01 x | 1.05 x | 1.5 x | 1.1 x | 2.08 x |
EV / Revenue | 1.41 x | 1.01 x | 1.13 x | 1.55 x | 1.16 x | 2.16 x |
EV / EBITDA | 18.4 x | 16.3 x | 17.7 x | 23.1 x | 21.2 x | 24.8 x |
EV / FCF | -5.97 x | 24.1 x | -14.5 x | 29.3 x | -56.8 x | -78 x |
FCF Yield | -16.8% | 4.16% | -6.87% | 3.41% | -1.76% | -1.28% |
Price to Book | 1.62 x | 1.59 x | 1.72 x | 1.74 x | 1.7 x | 3.18 x |
Nbr of stocks (in thousands) | 3,300 | 3,300 | 3,300 | 3,300 | 3,300 | 3,300 |
Reference price 2 | 30.15 | 30.20 | 33.00 | 34.10 | 34.45 | 69.65 |
Announcement Date | 18-09-06 | 19-05-30 | 20-09-08 | 21-09-07 | 22-09-07 | 23-09-06 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 73.24 | 98.57 | 103.4 | 75.1 | 103.2 | 110.3 |
EBITDA 1 | 5.611 | 6.079 | 6.618 | 5.054 | 5.642 | 9.608 |
EBIT 1 | 1.092 | 1.811 | 2.566 | 1.741 | 2.729 | 6.433 |
Operating Margin | 1.49% | 1.84% | 2.48% | 2.32% | 2.65% | 5.83% |
Earnings before Tax (EBT) 1 | 1.807 | 2.069 | 1.824 | 2.018 | 2.852 | 6.585 |
Net income 1 | 0.9575 | 1.232 | 1.124 | 1.229 | 2.152 | 5.729 |
Net margin | 1.31% | 1.25% | 1.09% | 1.64% | 2.09% | 5.2% |
EPS 2 | 0.2901 | 0.3734 | 0.3405 | 0.3724 | 0.6521 | 1.736 |
Free Cash Flow 1 | -17.28 | 4.122 | -8.046 | 3.984 | -2.104 | -3.051 |
FCF margin | -23.59% | 4.18% | -7.78% | 5.3% | -2.04% | -2.77% |
FCF Conversion (EBITDA) | - | 67.81% | - | 78.83% | - | - |
FCF Conversion (Net income) | - | 334.54% | - | 324.15% | - | - |
Dividend per Share 2 | 0.0500 | 0.0500 | 0.0500 | 0.0500 | 0.0500 | 0.0500 |
Announcement Date | 18-09-06 | 19-05-30 | 20-09-08 | 21-09-07 | 22-09-07 | 23-09-06 |
Balance Sheet Analysis
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 3.62 | - | 8.14 | 4.13 | 5.78 | 8 |
Net Cash position 1 | - | 0.48 | - | - | - | - |
Leverage (Debt/EBITDA) | 0.6459 x | - | 1.231 x | 0.8175 x | 1.024 x | 0.8328 x |
Free Cash Flow 1 | -17.3 | 4.12 | -8.05 | 3.98 | -2.1 | -3.05 |
ROE (net income / shareholders' equity) | 1.98% | 1.99% | 1.78% | 1.92% | 3.28% | 8.25% |
ROA (Net income/ Total Assets) | 0.73% | 1.09% | 1.63% | 1.18% | 1.79% | 4.11% |
Assets 1 | 131.9 | 112.9 | 68.83 | 104.1 | 120.1 | 139.3 |
Book Value Per Share 2 | 18.60 | 19.00 | 19.20 | 19.60 | 20.20 | 21.90 |
Cash Flow per Share 2 | 4.670 | 3.560 | 0.8800 | 1.860 | 1.250 | 0.5800 |
Capex 1 | 0.12 | 3.85 | 0.16 | 1.71 | 1.18 | 6.61 |
Capex / Sales | 0.16% | 3.91% | 0.15% | 2.27% | 1.14% | 6% |
Announcement Date | 18-09-06 | 19-05-30 | 20-09-08 | 21-09-07 | 22-09-07 | 23-09-06 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+2.53% | 4.94M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- KMSMEDI6 Stock
- Financials KMS Medisurgi Limited